Document is current
Any future updates will be listed below
-
Authors
Soh, Cheng Hwee
Smith, Joel
Shrestha, Shristy
Nolan, Mark
Wong, Joshua
Nerlekar, Nitesh
Marwick, Thomas H.
-
Funding
Funding for this research was provided by:
National Health and Medical Research Council (2008129)
- License Information
-
More Information
Article History
Received: 20 September 2024
Accepted: 23 January 2025
First Online: 4 February 2025
Declarations
:
: The REDEEM-CAD study is a prospective multicentre study approved by the Alfred HREC (project number HREC/84073/Alfred-2022), under the National Mutual Acceptance (NMA) scheme by the Ethics Committee. The study is also registered under the clinical trial number NCT05366153. Consent for participation in the REDEEM-CAD study will be obtained for all participants.
: Not applicable.
: The authors declare no competing interests.
